David Vlahov, RN, PhD, FAAN

Dean & Professor

Overview

Dr. Vlahov is Dean and Professor at the University of California, San Francisco School of Nursing. He brings experience in inter-professional and interdisciplinary education and research. He served on the faculty as Professor of Epidemiology at the Johns Hopkins and Columbia Universities, and was Adjunct Professor in Medical Schools at Cornell, Mount Sinai and New York University and the College of Nursing at New York University. He has also served as co-Director of the Robert Wood Johnson Foundation Health and Society Scholars program. He brings research expertise in epidemiology, infectious diseases, substance abuse and mental health. Dr. Vlahov conducted studies of urban populations in Baltimore for over 20 years including several longitudinal cohort studies for which he received the NIH MERIT Award. More recently, Dr. Vlahov led epidemiologic studies in Harlem and the Bronx, which have served as a platform for subsequent individual- and community-level intervention studies and community based participatory research (involving partnerships with residents, community based organizations, academic/ public health departments) to address social determinants of health. This work has contributed information on racial/ethnic disparities in health and approaches to address such disparities. Uniting these interests, Dr. Vlahov initiated the International Society for Urban Health (www.isuh.org), serving as its first President. He was a Visiting Professor at the Medical School in Belo Horizonte, Brazil to develop their programs in urban health, and has been an expert consultant to the WHO’s Urban Health Center in Kobe, Japan. He served on the New York City Board of Health. Dr. Vlahov is the editor-in-chief of the Journal of Urban Health, has edited three books on urban health and published over 640 scholarly papers. He is a member of the Institute of Medicine and a Fellow of the American Academy of Nursing.

Interests

Publications

A pivotal moment for urban health. Cad Saude Publica. 2015 Nov; 31 Suppl 1:7-8.
Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan. Harm Reduct J. 2015; 12(1):22.
The CHANGE Study: Methods and Sample Description for a Cross-Sectional Study of Heroin Cessation in New York City. J Urban Health. 2015 Oct; 92(5):955-65.
Impact of conflict and displacement on risk behaviours amongst people who inject drugs in Kabul, Afghanistan. Int J Drug Policy. 2016 Jan; 27:173-7.
Incarceration and injection drug use in Baltimore, Maryland. Addiction. 2015 Jul; 110(7):1152-9.
Clinical Risk Factors for In-hospital Adverse Cardiovascular Events After Acute Drug Overdose. Acad Emerg Med. 2015 May; 22(5):499-507.
Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Dec 15; 67(5):508-13.
Neighborhood characteristics and sexual intimate partner violence against women among low-income, drug-involved New York City residents: results from the IMPACT Studies. Violence Against Women. 2014 Jul; 20(7):799-824.
Understanding prolonged cessation from heroin use: findings from a community-based sample. J Psychoactive Drugs. 2014 Apr-Jun; 46(2):123-32.
Racial susceptibility for QT prolongation in acute drug overdoses. J Electrocardiol. 2014 Mar-Apr; 47(2):244-50.
Revisiting the role of the urban environment in substance use: the case of analgesic overdose fatalities. Am J Public Health. 2013 Dec; 103(12):2252-60.
On the role of genetic testing for personalized drug overdose management. J Med Toxicol. 2013 Sep; 9(3):294-5.
Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland. Addict Behav. 2013 Dec; 38(12):2868-73.
Resources and interest among faith based organizations for influenza vaccination programs. J Immigr Minor Health. 2013 Aug; 15(4):758-63.
Opioid receptor polymorphism A118G associated with clinical severity in a drug overdose population. J Med Toxicol. 2013 Jun; 9(2):148-54.
Alcohol consumption trajectory patterns in adult women with HIV infection. AIDS Behav. 2013 Jun; 17(5):1705-12.
Neighborhoods and HIV: a social ecological approach to prevention and care. Am Psychol. 2013 May-Jun; 68(4):210-24.
Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. Drug Alcohol Depend. 2013 Sep 1; 132(1-2):53-62.
Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users. AIDS. 2012 Nov 28; 26(18):2383-91.
Pediatric prehospital evaluation of NYC respiratory arrest survival (PHENYCS). Pediatr Emerg Care. 2012 Sep; 28(9):859-63.
Commentary on: Meta-analysis and public policy: opportunity for nursing impact. Nurs Outlook. 2012 Sep-Oct; 60(5):302-4.
Pediatric prehospital evaluation of NYC cardiac arrest survival (PHENYCS). Pediatr Emerg Care. 2012 Sep; 28(9):864-8.
Navigating non-positivity in neighbourhood studies: an analysis of collective efficacy and violence. J Epidemiol Community Health. 2013 Feb; 67(2):159-65.
Readmission risk factors after hospital discharge among the elderly. Popul Health Manag. 2012 Dec; 15(6):338-51.
Incidence of adverse cardiovascular events in adults following drug overdose. Acad Emerg Med. 2012 Jul; 19(7):843-9.
Factors associated with differential uptake of seasonal influenza immunizations among underserved communities during the 2009-2010 influenza season. J Community Health. 2012 Apr; 37(2):282-7.
Economic conditions and suicide rates in New York City. Am J Epidemiol. 2012 Mar 15; 175(6):527-35.
Cardiovascular disease risk assessment and prevention in blood donors. Transfusion. 2012 Oct; 52(10):2174-82.
Health behaviors and occupational stress of Brazilian civil servants living in an urban center. Am J Ind Med. 2013 Jan; 56(1):49-57.
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 2011 Nov; 22(11):2129-37.
Roundtable on Urban Living Environment Research (RULER). J Urban Health. 2011 Oct; 88(5):793-857.
No data, no problem, no action: addressing urban health inequity in the 21st century. J Urban Health. 2011 Oct; 88(5):858-9.
Addressing the social and environmental determinants of urban health equity: evidence for action and a research agenda. J Urban Health. 2011 Oct; 88(5):860-74.
Street-outreach improves detection but not referral for drug users with latent tuberculosis, New York City. Subst Use Misuse. 2011; 46(14):1711-5.
Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment. Harm Reduct J. 2011; 8:22.
Beyond income: material resources among drug users in economically-disadvantaged New York City neighborhoods. Drug Alcohol Depend. 2012 Jan 1; 120(1-3):127-34.
Integration of buprenorphine for substance-abuse treatment by HIV care providers. J Acquir Immune Defic Syndr. 2011 Mar 1; 56 Suppl 1:S1-2.
Changes in blood-borne infection risk among injection drug users. J Infect Dis. 2011 Mar 1; 203(5):587-94.
Intimate partner violence perpetration and condom use-related factors: associations with heterosexual men's consistent condom use. AIDS Behav. 2011 Jan; 15(1):153-62.
HIV risk behaviors among young drug using women who have sex with women (WSWs) in New York City. Subst Use Misuse. 2011; 46(2-3):274-84.
Comparison of HIV risk by duration of injection drug use. Subst Use Misuse. 2011; 46(2-3):181-91.
Progress in HIV reduction and prevention among injection and noninjection drug users. J Acquir Immune Defic Syndr. 2010 Dec; 55 Suppl 2:S84-7.
Reducing drug use, human immunodeficiency virus risk, and recidivism among young men leaving jail: evaluation of the REAL MEN re-entry program. J Adolesc Health. 2010 Nov; 47(5):448-55.
Policing and risk of overdose mortality in urban neighborhoods. Drug Alcohol Depend. 2011 Jan 1; 113(1):62-8.
HIV and proteinuria in an injection drug user population. Clin J Am Soc Nephrol. 2010 Oct; 5(10):1836-43.
Utility of serum lactate to predict drug-overdose fatality. Clin Toxicol (Phila). 2010 Aug; 48(7):730-6.
Medical examiner and medical toxicologist agreement on cause of death. Forensic Sci Int. 2011 Mar 20; 206(1-3):71-6.
Prevention of HIV infection among injection drug users in resource-limited settings. Clin Infect Dis. 2010 May 15; 50 Suppl 3:S114-21.
Investigating the effect of social changes on age-specific gun-related homicide rates in New York City during the 1990s. Am J Public Health. 2010 Jun; 100(6):1107-15.
Ambient temperature and risk of death from accidental drug overdose in New York City, 1990-2006. Addiction. 2010 Jun; 105(6):1049-54.
Intimate partner violence and consistent condom use among drug-using heterosexual women in New York City. Women Health. 2010 Mar; 50(2):107-24.
Neighborhood poverty and injection cessation in a sample of injection drug users. Am J Epidemiol. 2010 Feb 15; 171(4):391-8.
The influence of a major disaster on suicide risk in the population. J Trauma Stress. 2009 Dec; 22(6):481-8.
HCV infection and cryptogenic cirrhosis are risk factors for hepatocellular carcinoma among Latinos in New York City. J Community Health. 2009 Dec; 34(6):500-5.
Patterns and predictors of trajectories of depression after an urban disaster. Ann Epidemiol. 2009 Nov; 19(11):761-70.
The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART. J Med Virol. 2009 Aug; 81(8):1323-35.
Lack of association between estimated World Trade Center plume intensity and respiratory symptoms among New York City residents outside of Lower Manhattan. Am J Epidemiol. 2009 Sep 1; 170(5):640-9.
Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care. 2009 Jul; 21(7):834-41.
Misdemeanor policing, physical disorder, and gun-related homicide: a spatial analytic test of "broken-windows" theory. Epidemiology. 2009 Jul; 20(4):533-41.
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med. 2009 Aug; 49(1):68-73.
The bottom line on cash incentives with drug users. Addiction. 2009 May; 104(5):796-7.
Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. Am J Epidemiol. 2009 Apr 15; 169(8):1025-32.
Neighborhood characteristics and disability in older adults. J Gerontol B Psychol Sci Soc Sci. 2009 Mar; 64(2):252-7.
Bayesian hierarchical spatial modeling of substance abuse patterns following a mass trauma: the role of time and place. Subst Use Misuse. 2009; 44(12):1725-43.
Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users. J Acquir Immune Defic Syndr. 2008 Dec 15; 49(5):532-7.
Inference for cumulative incidence functions with informatively coarsened discrete event-time data. Stat Med. 2008 Dec 10; 27(28):5861-79.
Mitochondrial DNA haplogroups influence AIDS progression. AIDS. 2008 Nov 30; 22(18):2429-39.
Epidemiology of subway-related fatalities in New York City, 1990-2003. J Safety Res. 2008; 39(6):583-8.
Neighborhood characteristics and change in depressive symptoms among older residents of New York City. Am J Public Health. 2009 Jul; 99(7):1308-14.
Suicide in older adults in long-term care: 1990 to 2005. J Am Geriatr Soc. 2008 Nov; 56(11):2107-11.
Correlates of illicit methadone use in New York City: a cross-sectional study. BMC Public Health. 2008; 8:375.
Sensitivity analysis using elicited expert information for inference with coarsened data: illustration of censored discrete event times in the AIDS Link to Intravenous Experience (ALIVE) Study. Am J Epidemiol. 2008 Dec 15; 168(12):1460-9.
Longitudinal population-based studies of affective disorders: where to from here? BMC Psychiatry. 2008; 8:83.
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008 Oct; 40(10):1175-84.
Neighborhood-level correlates of consistent condom use among men who have sex with men: a multi-level analysis. AIDS Behav. 2010 Aug; 14(4):974-85.
Alcohol use trajectories among adults in an urban area after a disaster: evidence from a population-based cohort study. Addiction. 2008 Aug; 103(8):1296-307.
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS. 2008 Jul 11; 22(11):1355-63.
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis. 2008 Jun 15; 46(12):1852-8.
Prevalence and correlates of previous hepatitis B vaccination and infection among young drug-users in New York City. J Community Health. 2008 Jun; 33(3):139-48.
Limited uptake of hepatitis C treatment among injection drug users. J Community Health. 2008 Jun; 33(3):126-33.
Project VIVA: a multilevel community-based intervention to increase influenza vaccination rates among hard-to-reach populations in New York City. Am J Public Health. 2008 Jul; 98(7):1314-21.
Predictors of influenza vaccination in an urban community during a national shortage. J Health Care Poor Underserved. 2008 May; 19(2):611-24.
Trajectory and socioeconomic predictors of depression in a prospective study of residents of New York City. Ann Epidemiol. 2008 Mar; 18(3):235-43.
Previous cancer screening behavior as predictor of endoscopic colon cancer screening among women aged 50 and over, in NYC 2002. J Community Health. 2008 Feb; 33(1):10-21.
Sampling and recruitment in multilevel studies among marginalized urban populations: the IMPACT studies. J Urban Health. 2008 Mar; 85(2):268-80.
Mortality risk among recent-onset injection drug users in five U.S. cities. Subst Use Misuse. 2008; 43(3-4):413-28.
Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse. 2008; 34(2):161-70.
The role of community-academic partnerships: implications for medical education, research, and patient care. Prog Community Health Partnersh. 2008; 2(1):55-60.
Longitudinal determinants of posttraumatic stress in a population-based cohort study. Epidemiology. 2008 Jan; 19(1):47-54.
End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007 Nov 30; 21(18):2435-43.
What we can learn from the INSPIRE Study about improving prevention and clinical care for injection drug users living with HIV. J Acquir Immune Defic Syndr. 2007 Nov 1; 46 Suppl 2:S31-4.
Pandemic preparedness and hard to reach populations. Am J Disaster Med. 2007 Nov-Dec; 2(6):281-3.
What predicts psychological resilience after disaster? The role of demographics, resources, and life stress. J Consult Clin Psychol. 2007 Oct; 75(5):671-82.
Suicide tourism in Manhattan, New York City, 1990-2004. J Urban Health. 2007 Nov; 84(6):755-65.
Differences among U.S. states in estimating the number of people living with HIV/AIDS: impact on allocation of federal Ryan White funding. Public Health Rep. 2007 Sep-Oct; 122(5):644-56.
The built environment and alcohol consumption in urban neighborhoods. Drug Alcohol Depend. 2007 Dec 1; 91(2-3):244-52.
Strategies for improving influenza immunization rates among hard-to-reach populations. J Urban Health. 2007 Jul; 84(4):615-31.
Effect of micronutrients and iron supplementation on hemoglobin, iron status, and plasma hepatitis C and HIV RNA levels in female injection drug users: a controlled clinical trial. J Acquir Immune Defic Syndr. 2007 Jul 1; 45(3):298-303.
Explaining racial disparities in incidence of and survival from out-of-hospital cardiac arrest. Am J Epidemiol. 2007 Sep 1; 166(5):534-43.
Improving survival among HIV-infected injection drug users: how should we define success? Clin Infect Dis. 2007 Aug 1; 45(3):377-80.
Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007 Jul; 14(7):616-23.
Defining neighborhood boundaries for urban health research. Am J Prev Med. 2007 Jun; 32(6 Suppl):S154-9.
Access to influenza vaccine in East Harlem and the Bronx during a national vaccine shortage. J Community Health. 2007 Jun; 32(3):195-202.
Neighborhood income and income distribution and the use of cigarettes, alcohol, and marijuana. Am J Prev Med. 2007 Jun; 32(6 Suppl):S195-202.
HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007 Jul 1; 45(1):103-10.
Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug users. Addiction. 2007 May; 102(5):771-7.
Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users. AIDS Care. 2007 May; 19(5):637-45.
Social determinants of the health of urban populations: methodologic considerations. J Urban Health. 2007 May; 84(3 Suppl):i42-53.
Urban as a determinant of health. J Urban Health. 2007 May; 84(3 Suppl):i16-26.
Urban neighborhood poverty and the incidence of depression in a population-based cohort study. Ann Epidemiol. 2007 Mar; 17(3):171-9.
Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug Alcohol Depend. 2007 Jun 15; 89(1):74-81.
Adherence and retention of female injection drug users in a phase III clinical trial in inner city Baltimore. Am J Drug Alcohol Abuse. 2007; 33(1):71-80.
Television watching and the risk of incident probable posttraumatic stress disorder: a prospective evaluation. J Nerv Ment Dis. 2007 Jan; 195(1):41-7.
Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002. J Womens Health (Larchmt). 2007 Jan-Feb; 16(1):46-56.
Rapid vaccine distribution in nontraditional settings: lessons learned from project VIVA. J Community Health Nurs. 2007; 24(2):79-85.
Prevalence and risk factors for bloodborne exposure and infection in correctional healthcare workers. Infect Control Hosp Epidemiol. 2007 Jan; 28(1):24-30.
Buprenorphine use: the international experience. Clin Infect Dis. 2006 Dec 15; 43 Suppl 4:S197-215.
Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007 Jan; 97(1):117-24.
Education inequality and use of cigarettes, alcohol, and marijuana. Drug Alcohol Depend. 2007 Sep; 90 Suppl 1:S4-15.
Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. AIDS Care. 2006 Nov; 18(8):1040-5.
HIV incidence among injection drug users in Baltimore, Maryland (1988-2004). J Acquir Immune Defic Syndr. 2006 Nov 1; 43(3):368-72.
The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings. AIDS Behav. 2006 Nov; 10(6):717-21.
Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City. AIDS Behav. 2006 Nov; 10(6):707-15.
Challenges and facilitating factors in sustaining community-based participatory research partnerships: lessons learned from the Detroit, New York City and Seattle Urban Research Centers. J Urban Health. 2006 Nov; 83(6):1022-40.
Multiperson use of syringes among injection drug users in a needle exchange program: a gene-based molecular epidemiologic analysis. J Acquir Immune Defic Syndr. 2006 Nov 1; 43(3):335-43.
Psychological resources protect health: 5-year survival and immune function among HIV-infected women from four US cities. AIDS. 2006 Sep 11; 20(14):1851-60.
Response to overdose among injection drug users. Am J Prev Med. 2006 Sep; 31(3):261-4.
Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2006 Jul; 42(3):293-7.
Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol. 2006 Jul; 80(14):6757-63.
Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Educ Behav. 2007 Apr; 34(2):390-403.
Distribution of influenza vaccine to high-risk groups. Epidemiol Rev. 2006; 28:54-70.
Determinants of influenza vaccination in hard-to-reach urban populations. Prev Med. 2006 Jul; 43(1):60-70.
From corrections to communities as an HIV priority. J Urban Health. 2006 May; 83(3):339-48.
The effects of illicit drug use and HIV infection on sex hormone levels in women. Gynecol Endocrinol. 2006 May; 22(5):244-51.
Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death. Cad Saude Publica. 2006 Apr; 22(4):705-18.
What explains the association between neighborhood-level income inequality and the risk of fatal overdose in New York City? Soc Sci Med. 2006 Aug; 63(3):662-74.
The urban environment and sexual risk behavior among men who have sex with men. J Urban Health. 2006 Mar; 83(2):308-24.
Psychological resilience after disaster: New York City in the aftermath of the September 11th terrorist attack. Psychol Sci. 2006 Mar; 17(3):181-6.
Evaluation of an intervention to increase screening colonoscopy in an urban public hospital setting. J Urban Health. 2006 Mar; 83(2):231-43.
The relationship between self-reported sexual orientation and behavior in a sample of middle-aged male injection drug users. Arch Sex Behav. 2006 Feb; 35(1):67-74.
PTSD and depression after the Madrid March 11 train bombings. J Trauma Stress. 2006 Feb; 19(1):69-80.
Primary care and health insurance among women released from New York City jails. J Health Care Poor Underserved. 2006 Feb; 17(1):200-17.
Stigmatization of newly emerging infectious diseases: AIDS and SARS. Am J Public Health. 2006 Mar; 96(3):561-7.
Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose. J Addict Dis. 2006; 25(3):79-87.
Predictors of peritraumatic reactions and PTSD following the September 11th terrorist attacks. Psychiatry. 2006; 69(2):130-41.
Integrating HIV prevention activities into the HIV medical care setting: a report from the NYC HIV Centers Consortium. J Urban Health. 2006 Jan; 83(1):18-30.
Alcohol drinking problems among New York City residents after the September 11 terrorist attacks. Subst Use Misuse. 2006; 41(9):1295-311.
Support for buprenorphine and methadone prescription to heroin-dependent patients among New York City physicians. Am J Drug Alcohol Abuse. 2006; 32(1):1-6.
Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res Hum Retroviruses. 2006 Jan; 22(1):14-21.
Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug Alcohol Depend. 2006 Jun 28; 83(2):147-56.
Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes Immun. 2005 Dec; 6(8):691-8.
Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women: a report from the Women's Interagency HIV Study. J Subst Abuse Treat. 2005 Dec; 29(4):329-37.
Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. J Psychoactive Drugs. 2005 Dec; 37(4):437-43.
Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006 Jun 28; 83(2):104-10.
Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis. 2006 Jan 1; 193(1):16-26.
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med. 2005 Dec; 11(12):1290-2.
Period and birth-cohort effects on age of first phencyclidine (PCP) use among drug users in New York City, 1960 to 2000. Ann Epidemiol. 2006 Apr; 16(4):266-72.
Hepatitis B vaccination in correctional health care workers. Am J Infect Control. 2005 Nov; 33(9):510-8.
Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial. Vaccine. 2006 Mar 6; 24(10):1670-9.
Urban built environment and depression: a multilevel analysis. J Epidemiol Community Health. 2005 Oct; 59(10):822-7.
Ecstasy use and its association with sexual behaviors among drug users in New York City. J Community Health. 2005 Oct; 30(5):331-43.
Injection drug use is an independent risk factor for iron deficiency and iron deficiency anemia among HIV-seropositive and HIV-seronegative women. J Acquir Immune Defic Syndr. 2005 Oct 1; 40(2):198-201.
A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. AIDS. 2005 Oct; 19 Suppl 3:S179-89.
Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy. AIDS Behav. 2005 Sep; 9(3):289-99.
Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS Behav. 2005 Sep; 9(3):301-9.
Liver enzyme values in injection drug users with chronic hepatitis C. Dig Liver Dis. 2005 Sep; 37(9):674-80.
Community incidence of hepatitis B and C among reincarcerated women. Clin Infect Dis. 2005 Oct 1; 41(7):998-1002.
The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis. 2005 Oct 1; 41(7):1027-34.
Invited commentary: Considering bias in the assessment of respiratory symptoms among residents of Lower Manhattan following the events of September 11, 2001. Am J Epidemiol. 2005 Sep 15; 162(6):508-10; discussion 511-2.
Interpersonal predictors of depression trajectories in women with HIV. J Consult Clin Psychol. 2005 Aug; 73(4):678-88.
Income inequality and risk of suicide in New York City neighborhoods: a multilevel case-control study. Suicide Life Threat Behav. 2005 Aug; 35(4):448-59.
Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005 Aug 1; 39(4):471-7.
The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction. 2005 Jul; 100(7):990-1002.
The effect of HIV infection on overdose mortality. AIDS. 2005 Jun 10; 19(9):935-42.
Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. Am J Epidemiol. 2005 Jun 1; 161(11):999-1012.
Risk of tuberculosis in correctional healthcare workers. J Occup Environ Med. 2005 Jun; 47(6):580-6.
The urban built environment and overdose mortality in New York City neighborhoods. Health Place. 2005 Jun; 11(2):147-56.
Perspectives on urban conditions and population health. Cad Saude Publica. 2005 May-Jun; 21(3):949-57.
Toward an urban health advantage. J Public Health Manag Pract. 2005 May-Jun; 11(3):256-8.
Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend. 2005 Sep 1; 79(3):389-95.
The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users. J Acquir Immune Defic Syndr. 2005 Apr 15; 38(5):584-9.
Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health. 2005 Apr; 95(4):689-95.
Childhood sexual abuse and age at initiation of injection drug use. Am J Public Health. 2005 Apr; 95(4):703-9.
Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. Arch Intern Med. 2005 Mar 28; 165(6):690-5.
Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis. 2005 Apr 1; 40(7):951-8.
Drug and alcohol use as determinants of New York City homicide trends from 1990 to 1998. J Forensic Sci. 2005 Mar; 50(2):470-4.
Drug use, misuse, and the urban environment. Drug Alcohol Rev. 2005 Mar; 24(2):127-36.
Cities and population health. Soc Sci Med. 2005 Mar; 60(5):1017-33.
The urban health "advantage". J Urban Health. 2005 Mar; 82(1):1-4.
A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000-2003. J Urban Health. 2005 Mar; 82(1 Suppl 1):i51-61.
Introduction: new dynamics of HIV risk among drug-using men who have sex with men. J Urban Health. 2005 Mar; 82(1 Suppl 1):i1-8.
Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug Alcohol Depend. 2005 Aug 1; 79(2):181-90.
Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals. J Infect Dis. 2005 Mar 15; 191(6):881-5.
Beyond urban penalty and urban sprawl: back to living conditions as the focus of urban health. J Community Health. 2005 Feb; 30(1):1-11.
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics. 2005 Apr 14; 21(2):212-21.
Correlates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, Maryland. Subst Use Misuse. 2005; 40(12):1751-64.
The epidemiology of post-traumatic stress disorder after disasters. Epidemiol Rev. 2005; 27:78-91.
Body habitus in a cohort of HIV-seropositive and HIV-seronegative injection drug users. AIDS Patient Care STDS. 2005 Jan; 19(1):19-30.
Ecstasy use among Hispanic and black substance users in New York City. Subst Use Misuse. 2005; 40(9-10):1399-407.
Suicidal ideation among African-American non-injection drug users. Ethn Dis. 2005; 15(1):110-5.
Racial/ethnic differences in screening for colon cancer: report from the New York Cancer Project. Ethn Dis. 2005; 15(1):76-83.
Probable cigarette dependence, PTSD, and depression after an urban disaster: results from a population survey of New York City residents 4 months after September 11, 2001. Psychiatry. 2005; 68(4):299-310.
Urban health: evidence, challenges, and directions. Annu Rev Public Health. 2005; 26:341-65.
Reducing disparities in vaccination rates between different racial/ethnic and socioeconomic groups: the potential of community-based multilevel interventions. J Ambul Care Manage. 2005 Jan-Mar; 28(1):49-59.
Prognostic factors for survival differ according to CD4+ cell count among HIV-infected injection drug users: pre-HAART and HAART eras. J Acquir Immune Defic Syndr. 2005 Jan 1; 38(1):74-81.
Acceptance and completion of hepatitis B vaccination among drug users in New York City. Commun Dis Public Health. 2004 Dec; 7(4):294-300.
Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression. J Acquir Immune Defic Syndr. 2004 Dec 1; 37(4):1534-8.
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol. 2004 Dec; 78(24):14053-6.
Cities and health: history, approaches, and key questions. Acad Med. 2004 Dec; 79(12):1133-8.
The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy. AIDS. 2004 Nov 19; 18(17):2313-8.
Resilient children of injection drug users. J Am Acad Child Adolesc Psychiatry. 2004 Nov; 43(11):1372-9.
Gender, social support, and posttraumatic stress in postwar Kosovo. J Nerv Ment Dis. 2004 Nov; 192(11):762-70.
Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection. J Clin Virol. 2004 Nov; 31(3):210-4.
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J Virol. 2004 Oct; 78(20):11258-62.
Job loss, unemployment, work stress, job satisfaction, and the persistence of posttraumatic stress disorder one year after the September 11 attacks. J Occup Environ Med. 2004 Oct; 46(10):1057-64.
APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol. 2004 Oct; 78(20):11070-6.
Persistence of inconsistent condom use: relation to abuse history and HIV serostatus. AIDS Behav. 2004 Sep; 8(3):333-44.
Epidemiologic research and disasters. Ann Epidemiol. 2004 Sep; 14(8):532-4.
Hispanic ethnicity and post-traumatic stress disorder after a disaster: evidence from a general population survey after September 11, 2001. Ann Epidemiol. 2004 Sep; 14(8):520-31.
Club drug use among minority substance users in New York City. J Psychoactive Drugs. 2004 Sep; 36(3):397-9.
Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J Infect Dis. 2004 Sep 15; 190(6):1046-54.
Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend. 2004 Aug 16; 75(2):177-83.
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004 Aug 6; 305(5685):872-4.
Mortality risk among new onset injection drug users. Addiction. 2004 Aug; 99(8):946-54.
Overdose deaths attributed to methadone and heroin in New York City, 1990-1998. Addiction. 2004 Jul; 99(7):846-54.
Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004 Jul; 94(7):1218-23.
The New York Cancer Project: rationale, organization, design, and baseline characteristics. J Urban Health. 2004 Jun; 81(2):301-10.
An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection. Genes Immun. 2004 Jun; 5(4):294-300.
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health. 2004 Jun; 81(2):260-7.
MICA and recovery from hepatitis C virus and hepatitis B virus infections. Genes Immun. 2004 Jun; 5(4):261-6.
War-related psychological sequelae among emergency department patients in the former Republic of Yugoslavia. BMC Med. 2004 Jun 1; 2:22.
Transparent Reporting of Evaluations with Nonrandomized Designs (TREND). J Urban Health. 2004 Jun; 81(2):163-4.
Evaluation of possible effects of continued drug use on HIV progression among women. Int J STD AIDS. 2004 May; 15(5):322-7.
Consumption of cigarettes, alcohol, and marijuana among New York City residents six months after the September 11 terrorist attacks. Am J Drug Alcohol Abuse. 2004 May; 30(2):385-407.
High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. J Acquir Immune Defic Syndr. 2004 Apr 15; 35(5):503-10.
A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet. 2004 May; 74(5):1001-13.
Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clin Infect Dis. 2004 Apr 15; 38(8):1167-74.
War and anxiety disorders. Epidemiology. 2004 Mar; 15(2):129-30.
Mental health service and medication use in New York City after the September 11, 2001, terrorist attack. Psychiatr Serv. 2004 Mar; 55(3):274-83.
Television images and probable posttraumatic stress disorder after September 11: the role of background characteristics, event exposures, and perievent panic. J Nerv Ment Dis. 2004 Mar; 192(3):217-26.
Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City. J Urban Health. 2004 Mar; 81(1):20-4.
Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004 Mar; 81(1):14-9.
Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004 Feb; 33(1):182-8.
Sustained increased consumption of cigarettes, alcohol, and marijuana among Manhattan residents after september 11, 2001. Am J Public Health. 2004 Feb; 94(2):253-4.
Mental health status among ethnic Albanians seeking medical care in an emergency department two years after the war in Kosovo: a pilot project. Ann Emerg Med. 2004 Feb; 43(2):E1-8.
Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City. Clin Infect Dis. 2004 Feb 1; 38(3):438-41.
Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethn Dis. 2004; 14(4):589-96.
High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology. 2004 Jan; 39(1):51-7.
The social epidemiology of substance use. Epidemiol Rev. 2004; 26:36-52.
Retinoids and drugs of abuse: implications for neurological disease risk in human immunodeficiency virus type 1 infection. Clin Infect Dis. 2003 Dec 15; 37 Suppl 5:S427-32.
Understanding the dynamics of sexual transmission of HIV among drug-using populations: an integration of biological, behavioral, and environmental perspectives. J Urban Health. 2003 Dec; 80(4 Suppl 3):iii1-6.
Contextual determinants of drug use risk behavior: a theoretic framework. J Urban Health. 2003 Dec; 80(4 Suppl 3):iii50-8.
Relationship of self-reported asthma severity and urgent health care utilization to psychological sequelae of the September 11, 2001 terrorist attacks on the World Trade Center among New York City area residents. Psychosom Med. 2003 Nov-Dec; 65(6):993-6.
Urban health: a new discipline. Lancet. 2003 Oct 4; 362(9390):1091-2.
Commentary: Modelling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users. Int J Epidemiol. 2003 Oct; 32(5):715-6.
Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol. 2003 Oct 1; 158(7):695-704.
Awareness and perceptions of a communitywide mental health program in New York city after September 11. Psychiatr Serv. 2003 Oct; 54(10):1404-6.
Posttraumatic stress in women after the September 11 terrorist attacks in New York City. J Womens Health (Larchmt). 2003 Oct; 12(8):809-20.
Trends of probable post-traumatic stress disorder in New York City after the September 11 terrorist attacks. Am J Epidemiol. 2003 Sep 15; 158(6):514-24.
Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS. 2003 Sep 5; 17(13):1953-62.
Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2003 Aug 15; 33(5):614-24.
Children of HIV-positive drug-using parents. J Am Acad Child Adolesc Psychiatry. 2003 Aug; 42(8):950-6.
A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals. J Infect Dis. 2003 Jul 15; 188(2):228-31.
Hepatitis C virus infection among noninjecting drug users in New York City. J Med Virol. 2003 Jul; 70(3):387-90.
Psychiatric medication use among Manhattan residents following the World Trade Center disaster. J Trauma Stress. 2003 Jun; 16(3):301-6.
Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction. 2003 Jun; 98(6):739-47.
Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City. J Urban Health. 2003 Jun; 80(2):288-90.
Racial/ethnic disparities in overdose mortality trends in New York City, 1990-1998. J Urban Health. 2003 Jun; 80(2):201-11.
Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans. Genes Immun. 2003 Jun; 4(4):245-50.
Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug Alcohol Depend. 2003 May 21; 70(2):139-48.
Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors. AIDS Patient Care STDS. 2003 May; 17(5):211-9.
Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression. Immunogenetics. 2003 Jun; 55(3):157-64.
Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis. 2003 May 1; 187(9):1388-96.
Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users. Int J Cardiol. 2003 Apr; 88(2-3):191-8.
Psychological distress and progression to AIDS in a cohort of injection drug users. J Acquir Immune Defic Syndr. 2003 Apr 1; 32(4):429-34.
The role of Medicaid HMO enrollment in the longitudinal utilization of medical care services in a cohort of injecting drug users in Baltimore, Maryland. Subst Abus. 2003 Mar; 24(1):27-41.
Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003 Mar 1; 157(5):467-71.
Factors associated with human herpesvirus type 8 infection in an injecting drug user cohort. Sex Transm Dis. 2003 Mar; 30(3):199-204.
Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS. 2003 Feb 14; 17(3):377-87.
Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. J Acquir Immune Defic Syndr. 2003 Feb 1; 32(2):229-37.
Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. J Acquir Immune Defic Syndr. 2003 Jan 1; 32(1):86-93.
Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance. J Subst Abuse Treat. 2003 Jan; 24(1):67-74.
Incidence of violence against HIV-infected and uninfected women: findings from the HIV Epidemiology Research (HER) study. J Urban Health. 2002 Dec; 79(4):512-24.
Urbanization, urbanicity, and health. J Urban Health. 2002 Dec; 79(4 Suppl 1):S1-S12.
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002 Nov 8; 16(16):2175-82.
Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology. 2002 Nov; 13(6):738-41.
Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6 Suppl 2):S77-82.
More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6 Suppl 2):S62-7.
Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002 Oct; 14(5):367-78.
Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women. J Womens Health (Larchmt). 2002 Oct; 11(8):743-50.
Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol. 2002 Oct 1; 156(7):641-53.
Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. Am Heart J. 2002 Oct; 144(4):642-8.
Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. J Infect Dis. 2002 Oct 15; 186(8):1181-5.
Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis. 2002 Oct 1; 35(7):783-8.
Drug use frequency among street-recruited heroin and cocaine users in Harlem and the Bronx before and after September 11, 2001. J Urban Health. 2002 Sep; 79(3):404-8.
Posttraumatic stress disorder in Manhattan, New York City, after the September 11th terrorist attacks. J Urban Health. 2002 Sep; 79(3):340-53.
Regional variation in CCR5-Delta32 gene distribution among women from the US HIV Epidemiology Research Study (HERS). Genes Immun. 2002 Aug; 3(5):295-8.
An investigation of the psychological effects of the September 11, 2001, attacks on New York City: developing and implementing research in the acute postdisaster period. CNS Spectr. 2002 Aug; 7(8):585-7, 593-6.
Effect of cocaine use on coronary calcium among black adults in Baltimore, Maryland. Am J Cardiol. 2002 Aug 1; 90(3):326-8.
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002 Aug; 31(4):429-34.
Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci U S A. 2002 Jul 23; 99(15):10002-7.
Determinants of counseling for children in Manhattan after the September 11 attacks. Psychiatr Serv. 2002 Jul; 53(7):815-22.
Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr. 2002 Jul 1; 30(3):306-10.
Development of a "survival" guide for substance users in Harlem, New York City. Health Educ Behav. 2002 Jun; 29(3):312-25.
Self-efficacy estimates for drug use practices predict risk reduction among injection drug users. J Urban Health. 2002 Jun; 79(2):245-56.
Increased use of cigarettes, alcohol, and marijuana among Manhattan, New York, residents after the September 11th terrorist attacks. Am J Epidemiol. 2002 Jun 1; 155(11):988-96.
Access to resources for substance users in Harlem, New York City: service provider and client perspectives. Health Educ Behav. 2002 Jun; 29(3):296-311.
Prospective study of infective endocarditis among injection drug users. J Infect Dis. 2002 Jun 15; 185(12):1761-6.
Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. J Epidemiol Community Health. 2002 May; 56(5):349-53.
Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology. 2002 May; 35(5):1247-55.
HLA-Cw*04 and hepatitis C virus persistence. J Virol. 2002 May; 76(10):4792-7.
Protection against persistence of hepatitis C. Lancet. 2002 Apr 27; 359(9316):1478-83.
High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002 Apr 1; 66(2):189-98.
Psychological sequelae of the September 11 terrorist attacks in New York City. N Engl J Med. 2002 Mar 28; 346(13):982-7.
New York City, 2001: reaction and response. J Urban Health. 2002 Mar; 79(1):2-5.
Drugs and firearm deaths in New York City, 1990-1998. J Urban Health. 2002 Mar; 79(1):70-86.
Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse. 2002 Mar; 37(4):495-522.
Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program. J Urban Health. 2002 Mar; 79(1):113-27.
High prevalence of iron deficiency and anemia among female injection drug users with and without HIV infection. J Acquir Immune Defic Syndr. 2002 Feb 1; 29(2):142-4.
Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users. Int J STD AIDS. 2002 Feb; 13(2):119-23.
Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. Am J Epidemiol. 2002 Jan 15; 155(2):169-75.
Utilization of mental health services following the September 11th terrorist attacks in Manhattan, New York City. Int J Emerg Ment Health. 2002; 4(3):143-55.
Health services utilization by injection drug users participating in a needle exchange program. Am J Drug Alcohol Abuse. 2002; 28(3):497-511.
Drug user treatment referrals and entry among participants of a needle exchange program. Subst Use Misuse. 2002; 37(14):1869-86.
Television images and psychological symptoms after the September 11 terrorist attacks. Psychiatry. 2002; 65(4):289-300.
Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002; 117 Suppl 1:S135-45.
Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol. 2001 Dec 15; 154(12 Suppl):S70-7.
Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis. 2002 Jan 15; 34(2):260-6.
Evidence of rodent-associated Bartonella and Rickettsia infections among intravenous drug users from Central and East Harlem, New York City. Am J Trop Med Hyg. 2001 Dec; 65(6):855-60.
Cancer incidence in women with or at risk for HIV. Int J Cancer. 2001 Dec 1; 94(5):753-7.
Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS. 2001 Nov 23; 15(17):2311-6.
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med. 2001 Nov 6; 135(9):782-95.
Collaboration among community members, local health service providers, and researchers in an urban research center in Harlem, New York. Public Health Rep. 2001 Nov-Dec; 116(6):530-9.
Needle exchange programs and experience of violence in an inner city neighborhood. J Acquir Immune Defic Syndr. 2001 Nov 1; 28(3):282-8.
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. Clin Infect Dis. 2001 Nov 15; 33(10):1687-91.
Dynamics of SEN virus infection among injection drug users. J Infect Dis. 2001 Nov 15; 184(10):1315-9.
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS. 2001 Sep 7; 15(13):1707-15.
Influence of injection drug use behavior on reported antiretroviral therapy use among women in the HIV Epidemiology Research study: on-site versus referral care. J Acquir Immune Defic Syndr. 2001 Sep 1; 28(1):28-34.
Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug Alcohol Depend. 2001 Sep 1; 64(1):55-62.
Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care STDS. 2001 Sep; 15(9):473-80.
[The difference between men and women drug users in seroconversion risk factors]. Sidahora. 2001 Aug; 25-6.
Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors. Am J Respir Crit Care Med. 2001 Jul 1; 164(1):82-5.
Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health. J Urban Health. 2001 Jun; 78(2):340-9.
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med. 2001 May 31; 344(22):1668-75.
Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis. 2001 Jul 1; 184(1):16-21.
Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001 May 28; 161(10):1281-8.
Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem. J Womens Health Gend Based Med. 2001 May; 10(4):371-80.
Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001 Apr 1; 26(4):315-9.
Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J Virol. 2001 Apr; 75(7):3259-67.
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001 Mar 21; 285(11):1466-74.
Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med. 2001 Mar 8; 344(10):720-5.
Selective risk taking among needle exchange participants: implications for supplemental interventions. Am J Public Health. 2001 Mar; 91(3):406-11.
Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. Eur Addict Res. 2001 Mar; 7(1):40-5.
Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med. 2001 Mar 1; 344(9):637-43.
Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users. Drug Alcohol Depend. 2001 Feb 1; 61(3):315-22.
Injecting misuse of buprenorphine among French drug users. Addiction. 2001 Feb; 96(2):267-72.
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health. 2001 Jan; 91(1):23-30.
Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001; 116 Suppl 1:136-45.
Characteristics of injection drug using parents who retain their children. Drug Alcohol Depend. 2001 Jan 1; 61(2):113-22.
Health care utilization among young adult injection drug users in Harlem, New York. J Subst Abuse. 2001; 13(1-2):17-27.
Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. J Subst Abuse. 2001; 13(1-2):73-88.
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A. 2000 Dec 19; 97(26):14467-72.
The prevalence of homelessness among injection drug users with and without HIV infection. J Urban Health. 2000 Dec; 77(4):678-87.
New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health. 2000 Dec; 77(4):781-93.
New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation. J Urban Health. 2000 Dec; 77(4):768-80.
Trends in crime and the introduction of a needle exchange program. Am J Public Health. 2000 Dec; 90(12):1933-6.
Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. AIDS. 2000 Sep 29; 14(14):2117-22.
Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS. 2000 Sep 8; 14(13):2035-43.
Gender differences in the initiation of injection drug use among young adults. J Urban Health. 2000 Sep; 77(3):396-414.
Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). J Acquir Immune Defic Syndr. 2000 Sep 1; 25(1):63-70.
HTLV-II and bacterial infections among injection drug users. J Acquir Immune Defic Syndr. 2000 Aug 15; 24(5):483-7.
Short tandem repeat methodology for genotypic identification of single-person versus multi-person use of syringes. AIDS. 2000 Jul 28; 14(11):1507-13.
The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000 Jul 26; 284(4):450-6.
Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group. Drug Alcohol Depend. 2000 Jul 1; 60(1):51-4.
Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol. 2000 Jun 15; 151(12):1148-57.
Palliative care for HIV disease in the era of highly active antiretroviral therapy. J Urban Health. 2000 Jun; 77(2):150-65.
The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up. Am J Public Health. 2000 Jun; 90(6):936-9.
Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J Acquir Immune Defic Syndr. 2000 May 1; 24(1):57-61.
Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000 Apr 14; 14(6):717-26.
Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. J Acquir Immune Defic Syndr. 2000 Apr 1; 23(4):321-6.
Syringe exchange not associated with social network formation: results from Baltimore. AIDS. 2000 Mar 10; 14(4):423-6.
Determinants of the quantity of hepatitis C virus RNA. J Infect Dis. 2000 Mar; 181(3):844-51.
Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol. 2000 Feb; 38(2):575-7.
HIV testing and retesting for men and women in Switzerland. Eur J Epidemiol. 2000 Feb; 16(2):123-33.
Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health. 1999 Dec; 76(4):448-60.
Evaluating supervised HAART in late-stage HIV among drug users: a preliminary report. J Urban Health. 1999 Dec; 76(4):468-80.
The impact of multifocused interventions on sharps injury rates at an acute-care hospital. Infect Control Hosp Epidemiol. 1999 Dec; 20(12):806-11.
Syringe vending machines for injection drug users: an experiment in Marseille, France. Am J Public Health. 1999 Dec; 89(12):1852-4.
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis. 1999 Nov; 29(5):1145-50.
The effect of drug-injection behavior on genetic evolution of HIV-1. J Infect Dis. 1999 Oct; 180(4):1025-32.
Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load. J Infect Dis. 1999 Oct; 180(4):1018-24.
Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. J Acquir Immune Defic Syndr. 1999 Oct 1; 22(2):161-6.
Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. J Infect Dis. 1999 Sep; 180(3):666-72.
Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection. Clin Infect Dis. 1999 Sep; 29(3):608-12.
Re: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study". Am J Epidemiol. 1999 Aug 1; 150(3):325-6.
Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. Cancer Res. 1999 Aug 1; 59(15):3561-4.
The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research. Int J Tuberc Lung Dis. 1999 Aug; 3(8):681-8.
Serologic evidence of rickettsialpox (Rickettsia akari) infection among intravenous drug users in inner-city Baltimore, Maryland. Am J Trop Med Hyg. 1999 Jun; 60(6):894-8.
Controlled clinical evaluation of diacetyl morphine for treatment of intractable opiate dependence. Lancet. 1999 May 8; 353(9164):1543-4.
Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. J Infect Dis. 1999 May; 179(5):1297-300.
Pre-AIDS mortality and morbidity among injection drug users in Amsterdam and Baltimore: an ecological comparison. Subst Use Misuse. 1999 May; 34(6):845-65.
Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15; 20(5):448-54.
Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis. 1999 Apr; 179(4):1004-6.
New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users. Drug Alcohol Depend. 1999 Apr 1; 54(2):145-54.
Relationship between HIV-1 viral load and continued drug use in untreated infected injection drug users. Addict Biol. 1999 Apr; 4(2):197-202.
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science. 1999 Mar 12; 283(5408):1748-52.
Differing risk factors for cerebral palsy in the presence of mental retardation and epilepsy. J Child Neurol. 1999 Mar; 14(3):151-5.
Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology. 1999 Mar; 29(3):908-14.
HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug Alcohol Depend. 1999 Mar 1; 54(1):83-6.
Compliance with universal precautions in correctional health care facilities. J Occup Environ Med. 1999 Mar; 41(3):181-9.
Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Mar 1; 20(3):275-82.
A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology. 1999 Feb; 29(2):590-6.
Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men. Eur J Epidemiol. 1999 Feb; 15(2):99-108.
Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program. J Am Pharm Assoc (Wash). 1999 Jan-Feb; 39(1):17-22.
Criteria for assessing cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiologic Research Study Group. J Allergy Clin Immunol. 1999 Jan; 103(1 Pt 1):93-8.
Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions. Ann Ist Super Sanita. 1999; 35(3):435-41.
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. J Epidemiol Community Health. 1999 Jan; 53(1):4-8.
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science. 1998 Dec 4; 282(5395):1907-11.
Comparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups. J Clin Microbiol. 1998 Dec; 36(12):3647-52.
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA. 1998 Nov 18; 280(19):1679-84.
Sex differences in HIV-1 viral load and progression to AIDS. Lancet. 1998 Nov 7; 352(9139):1510-4.
Diversification of subtype E human immunodeficiency virus type 1 env in heterosexual seroconverters from Northern Thailand. J Infect Dis. 1998 Nov; 178(5):1507-11.
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12568-73.
Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease. AIDS. 1998 Aug 20; 12(12):1451-7.
Self-reported antiretroviral therapy in injection drug users. JAMA. 1998 Aug 12; 280(6):544-6.
HIV/HTLV-II coinfection and CD4+ cell count controlling for plasma HIV viral load in injection drug users in Baltimore. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 1; 18(4):397-8.
Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction. 1998 Aug; 93(8):1191-7.
Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users. J Infect Dis. 1998 Aug; 178(2):388-96.
Drug abuse treatment success among needle exchange participants. Public Health Rep. 1998 Jun; 113 Suppl 1:129-39.
Satellite exchange in the Baltimore Needle Exchange Program. Public Health Rep. 1998 Jun; 113 Suppl 1:90-6.
Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. AIDS Educ Prev. 1998 Jun; 10(3):257-63.
The role of needle exchange programs in HIV prevention. Public Health Rep. 1998 Jun; 113 Suppl 1:75-80.
Tuberculosis risk in funeral home employees. J Occup Environ Med. 1998 May; 40(5):497-503.
Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol. 1998 Mar 15; 83(1-2):77-87.
Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis. 1998 Mar; 177(3):539-42.
Vitamin A supplementation and human immunodeficiency virus load in injection drug users. J Infect Dis. 1998 Mar; 177(3):611-6.
Correlates of infection control practices in dentistry. Am J Infect Control. 1998 Feb; 26(1):29-34.
Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) Science. 1998 Jan 16; 279(5349):389-93.
Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA. 1998 Jan 7; 279(1):35-40.
Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S133-8.
Community support for needle exchange programs and pharmacy sale of syringes: a household survey in Baltimore, Maryland. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S82-8.
Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S11-9.
Use of sterile syringes and aseptic drug preparation are important components of HIV prevention among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S1-5.
Community-based programs for safe disposal of used needles and syringes. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S111-9.
Can HIV epidemics among injection drug users be prevented? AIDS. 1998; 12 Suppl A:S71-9.
Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S89-93.
Operation Red Box: a pilot project of needle and syringe drop boxes for injection drug users in East Baltimore. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S120-5.
Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 15; 16(5):400-6.
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol. 1997 Dec; 35(12):3274-7.
Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis. 1997 Nov; 176(5):1397-400.
Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression. Am J Epidemiol. 1997 Oct 1; 146(7):543-51.
Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol. 1997 Sep 15; 146(6):459-69.
Persistence and clinical significance of hepatitis G virus infections in injecting drug users. J Infect Dis. 1997 Sep; 176(3):586-92.
Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clin Infect Dis. 1997 Sep; 25(3):726-8.
Helper T-lymphocyte count. TRAx CD4 test kit versus conventional flow cytometry. Arch Pathol Lab Med. 1997 Sep; 121(9):960-2.
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science. 1997 Aug 15; 277(5328):959-65.
The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users. AIDS. 1997 Aug; 11(10):1255-62.
Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study. Antivir Ther. 1997 Jul; 2(3):167-74.
Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis. 1997 Jul; 176(1):144-50.
Postcoital vaginal bleeding as a risk factor for transmission of the human immunodeficiency virus in a heterosexual partner study in Brazil. Rio de Janeiro Heterosexual Study Group. Arch Intern Med. 1997 Jun 23; 157(12):1362-8.
Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol. 1997 May; 35(5):1244-7.
Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol. 1997 Apr 15; 145(8):730-7.
Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs. Int J STD AIDS. 1997 Apr; 8(4):225-8.
Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Apr 1; 14(4):355-60.
Drug use. Vancouver Conference Review. AIDS Care. 1997 Feb; 9(1):53-7.
Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection. J Clin Microbiol. 1997 Feb; 35(2):517-9.
African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel. Lancet. 1997 Jan 18; 349(9046):180-1.
HIV infection and cognition in intravenous drug users: long-term follow-up. Neurology. 1997 Jan; 48(1):223-30.
Vitamin A levels and human immunodeficiency virus load in injection drug users. Clin Diagn Lab Immunol. 1997 Jan; 4(1):93-5.
Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men. Neuroepidemiology. 1997; 16(2):78-85.
Tetanus and injections drug use: rediscovery of a neglected problem? Eur J Epidemiol. 1996 Dec; 12(6):655-6.
Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med. 1996 Nov 25; 156(21):2491-5.
HIV testing behaviors in a population of inner-city women at high risk for HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 1; 13(3):267-72.
The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study. Drug Alcohol Depend. 1996 Nov; 42(3):175-81.
People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 1; 13(3):273-80.
Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiology. 1996 Nov; 7(6):566-70.
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis. 1996 Oct; 174(4):690-5.
Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells. J Virol. 1996 Oct; 70(10):6947-54.
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996 Sep 27; 273(5283):1856-62.
Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group. BMJ. 1996 Sep 7; 313(7057):583-6.
Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. AIDS Res Hum Retroviruses. 1996 Aug 10; 12(12):1179-83.
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol. 1996 Aug 1; 157(3):1271-8.
The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users. J Infect Dis. 1996 Aug; 174(2):299-308.
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis. 1996 Aug; 174(2):309-17.
Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition. 1996 Jul-Aug; 12(7-8):496-501.
The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study. Am J Community Psychol. 1996 Jun; 24(3):341-64.
Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users. Clin Immunol Immunopathol. 1996 May; 79(2):134-41.
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996 May; 86(5):655-61.
Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med. 1996 Apr 22; 156(8):889-94.
Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis. Alcohol Clin Exp Res. 1996 Apr; 20(2):364-71.
Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Mar 1; 11(3):301-6.
Re: "Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study" and "Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991". Am J Epidemiol. 1996 Mar 1; 143(5):523-5; author reply 525-6.
Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J Infect Dis. 1996 Mar; 173(3):579-83.
Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study. Am J Epidemiol. 1996 Feb 1; 143(3):278-82.
Dilated heart muscle disease associated with HIV infection. Eur Heart J. 1995 Dec; 16 Suppl O:50-5.
Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Nov 1; 10(3):386-90.
Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Arch Intern Med. 1995 Oct 23; 155(19):2111-7.
Interest in HIV vaccines among Italian injection drug users. The Network Interregionale SERT. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1; 10(2):206-7.
Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1; 10(1):97-103.
Deregulation of the sale and possession of syringes for HIV prevention among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1; 10(1):71-2.
Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. Am J Epidemiol. 1995 Aug 1; 142(3):331-41.
Compliance with universal precautions among health care workers at three regional hospitals. Am J Infect Control. 1995 Aug; 23(4):225-36.
Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jul 1; 9(3):291-6.
Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore). 1995 Jul; 74(4):212-20.
Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch Intern Med. 1995 Jun 26; 155(12):1305-11.
Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study. AIDS. 1995 Jun; 9(6):597-604.
Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Int J Addict. 1995 May; 30(7):823-41.
Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1; 9(1):89-96.
Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis. 1995 May; 171(5):1196-202.
Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland. Infect Control Hosp Epidemiol. 1995 Apr; 16(4):194-7.
Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users. J Infect Dis. 1995 Apr; 171(4):797-804.
Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend. 1995 Apr; 38(1):1-9.
Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression. J Infect Dis. 1995 Apr; 171(4):822-8.
Age, gender, and other predictors of the wasting syndrome among HIV-1-infected injecting drug users. Epidemiology. 1995 Mar; 6(2):172-7.
Geographic variation in HIV infection among injecting drug users with Barcelona. Int J Addict. 1995 Jan; 30(2):219-29.
Review of accidents/injuries among emergency medical services workers in Baltimore, Maryland. Prehosp Disaster Med. 1995 Jan-Mar; 10(1):14-8.
Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1; 8(1):66-74.
Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med. 1994 Dec; 150(6 Pt 1):1493-8.
Improved detection of HTLV-II antibody using a whole viral lysate-based EIA. J Acquir Immune Defic Syndr. 1994 Dec; 7(12):1291-2.
Seoul hantavirus seropositivity among injecting drug users in Baltimore. J Infect Dis. 1994 Dec; 170(6):1636-7.
The evaluation of needle exchange programs. Am J Public Health. 1994 Dec; 84(12):1889-91.
Profile of HIV seropositive inmates diagnosed in Maryland's state correctional system. Public Health Rep. 1994 Nov-Dec; 109(6):756-60.
A community-based Needle Clean-Up Project. Am J Public Health. 1994 Nov; 84(11):1854.
Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend. 1994 Oct; 36(2):129-38.
Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol. 1994 Oct; 24(4):1025-32.
Correlates of attitudes concerning human immunodeficiency virus and acquired immunodeficiency syndrome among hospital workers. Am J Infect Control. 1994 Oct; 22(5):293-9.
Drug-related behavior change for HIV transmission among American injection drug users. Addiction. 1994 Oct; 89(10):1309-17.
Validation of the proposed World Health Organization staging system for disease and infection in a cohort of intravenous drug users. AIDS. 1994 Aug; 8(8):1129-33.
Low power? Use two-dimensional confidence regions as a graphical method for depicting uncertainty. Drug Alcohol Depend. 1994 Aug; 36(1):39-48.
Field effectiveness of needle disinfection among injecting drug users. J Acquir Immune Defic Syndr. 1994 Jul; 7(7):760-6.
Inadequate bleach contact times during syringe cleaning among injection drug users. J Acquir Immune Defic Syndr. 1994 Jul; 7(7):767-72.
Correlates of needle sharing among injection drug users. Am J Public Health. 1994 Jun; 84(6):920-3.
Comparison of clinical manifestations of HIV infection between male and female injecting drug users. AIDS. 1994 Jun; 8(6):819-23.
My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol. 1994 Jun; 22(3):415-30.
Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol. 1994 May 1; 139(9):918-26.
The relationships between sexual behavior, alcohol use, and personal network characteristics among injecting drug users in Baltimore, Maryland. Sex Transm Dis. 1994 May-Jun; 21(3):161-7.
Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users. Arch Intern Med. 1994 Apr 25; 154(8):869-75.
Temporal association between implementation of universal precautions and a sustained, progressive decrease in percutaneous exposures to blood. Clin Infect Dis. 1994 Apr; 18(4):562-9.
The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health. 1994 Mar; 84(3):382-7.
Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS. 1994 Mar; 8(3):345-50.
HIV seroconversion studies among intravenous drug users. AIDS. 1994 Feb; 8(2):263-5.
A pilot syringe exchange program in Washington, DC. Am J Public Health. 1994 Feb; 84(2):303-4.
Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. J Clin Epidemiol. 1994 Feb; 47(2):191-5.
Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users. Ann Epidemiol. 1994 Jan; 4(1):17-26.
Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses. 1994; 10 Suppl 2:S201-5.
Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev. 1994; 16(2):418-36.
HIV vaccines for injection drug users in the context of a comprehensive prevention agenda. AIDS Res Hum Retroviruses. 1994; 10 Suppl 2:S3-6.
Snake bite and antivenom complications in Belo Horizonte, Brazil. Trans R Soc Trop Med Hyg. 1994 Jan-Feb; 88(1):81-5.
Interest in HIV vaccines among injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses. 1994; 10 Suppl 2:S265-8.
Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol. 1993 Dec 1; 138(11):909-22.
Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med. 1993 Sep 27; 153(18):2149-54.
Household bleach as disinfectant for use by injecting drug users. Lancet. 1993 Sep 18; 342(8873):742-3.
Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol. 1993 Sep; 9(5):566-9.
Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men. Arch Intern Med. 1993 Aug 9; 153(15):1806-12.
Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users. J Infect Dis. 1993 Aug; 168(2):327-31.
Potential use of mass media to reach urban intravenous drug users with AIDS prevention messages. Int J Addict. 1993 Jul; 28(9):837-51.
Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. Am J Epidemiol. 1993 Apr 15; 137(8):892-8.
Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol. 1993 Apr 15; 71(11):955-8.
Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993 Apr; 88(4):517-26.
Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users. AIDS. 1993 Mar; 7(3):361-7.
Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human immunodeficiency virus seronegative intravenous drug users. Am J Cardiol. 1993 Feb 15; 71(5):446-7.
Incubation period of human immunodeficiency virus. Epidemiol Rev. 1993; 15(2):303-18.
Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. Am J Epidemiol. 1992 Dec 1; 136(11):1338-48.
Multidrug-resistant tuberculosis. N Engl J Med. 1992 Oct 15; 327(16):1172-3; author reply 1174.
Cancer of the pancreas and drinking water: a population-based case-control study in Washington County, Maryland. Am J Epidemiol. 1992 Oct 1; 136(7):836-42.
HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology. 1992 Oct; 42(10):1924-30.
Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep. 1992 Sep-Oct; 107(5):595-8.
Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry. 1992 Sep; 49(9):723-7.
Knowledge of therapeutics for human immunodeficiency virus infection among intravenous drug users. J Infect Dis. 1992 Sep; 166(3):685-6.
Needle-cleaning practices among intravenous drug users who share injection equipment in Baltimore, Maryland. Int J Addict. 1992 Jun; 27(6):717-25.
Terminology for drug injection practices among intravenous drug users in Baltimore. Int J Addict. 1992 Apr; 27(4):435-53.
Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA. 1992 Mar 25; 267(12):1631-6.
Measurement of HIV risk behaviors among intravenous drug users. Br J Addict. 1992 Mar; 87(3):417-28.
Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA. 1992 Jan 15; 267(3):369-73.
Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr. 1992; 5(7):694-700.
Characteristics of intravenous drug users by history of arrest and treatment for drug use. J Nerv Ment Dis. 1992 Jan; 180(1):48-54.
HIV-1 infection in the correctional setting. NIDA Res Monogr. 1992; 118:51-61.
Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr. 1992; 5(5):456-60.
Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment-program samples misleading? Br J Addict. 1992 Jan; 87(1):47-54.
Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med. 1991 Dec 26; 325(26):1837-42.
HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology. 1991 Dec; 41(12):1905-10.
New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol. 1991 Nov 15; 134(10):1175-89.
Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1991 Nov 15; 134(10):1206-11.
HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland. Epidemiology. 1991 Nov; 2(6):444-6.
Human immunodeficiency virus infection in diabetic intravenous drug users. JAMA. 1991 Oct 23-30; 266(16):2259-61.
Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health. 1991 Oct; 81(10):1291-5.
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health. 1991 Oct; 81(10):1285-90.
Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV). J Infect Dis. 1991 Sep; 164(3):457-63.
Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA. 1991 Mar 6; 265(9):1129-32.
The practice of 'frontloading' among intravenous drug users: association with HIV-antibody. AIDS. 1991 Mar; 5(3):343.
The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr. 1991; 109:75-100.
Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. Am J Drug Alcohol Abuse. 1991; 17(1):39-48.
Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides. J Acquir Immune Defic Syndr. 1991; 4(12):1190-8.
HIV infection risk to nonhealth-care workers. Am Ind Hyg Assoc J. 1990 Dec; 51(12):A807-9.
HIV infection risk to health-care workers. Am Ind Hyg Assoc J. 1990 Dec; 51(12):A802-6.
Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1990 Nov; 132(5):847-56.
Variation in risk for falls by clinical department: implications for prevention. Infect Control Hosp Epidemiol. 1990 Oct; 11(10):521-4.
The risk of transmission of HIV-1 through non-percutaneous, non-sexual modes--a review. AIDS. 1990 Jul; 4(7):645-50.
Coinfection with tuberculosis and HIV-1 in male prison inmates. Public Health Rep. 1990 May-Jun; 105(3):307-10.
Blood and plasma donations among a cohort of intravenous drug users. JAMA. 1990 Apr 25; 263(16):2194-7.
Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons: update. AIDS. 1990 Apr; 4(4):345-50.
Association between intravenous drug use and early misbehavior. Drug Alcohol Depend. 1990 Feb; 25(1):79-89.
Epidemiology of falls among patients in a rehabilitation hospital. Arch Phys Med Rehabil. 1990 Jan; 71(1):8-12.
Antibody to human T-lymphotropic virus type I/II (HTLV-I/II) among male inmates entering Maryland prisons. J Acquir Immune Defic Syndr. 1990; 3(5):531-5.
AIDS: overview, immunology, virology, and informational needs. Semin Oncol Nurs. 1989 Nov; 5(4):227-35.
Immunological effects of HIV-1 infection on the humoral response to malaria in an African population. Am J Trop Med Hyg. 1989 Nov; 41(5):504-11.
Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. J Med Virol. 1989 Nov; 29(3):181-5.
Gonorrhea prevalence in the Maryland state prisons. Sex Transm Dis. 1989 Oct-Dec; 16(4):165-7.
Further experience with the World Health Organization clinical case definition for AIDS in Uganda. AIDS. 1989 Jul; 3(7):462-3.
Why don't intravenous drug users use condoms? J Acquir Immune Defic Syndr. 1989; 2(4):416-7.
Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. J Acquir Immune Defic Syndr. 1989; 2(3):283-90.
Transmission of HIV-1 within a statewide prison system. AIDS. 1988 Oct; 2(5):363-7.
Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Control. 1988 Feb; 16(1):3-6.
Perspectives on infection with HIV-1 among intravenous drug users. Psychopharmacol Bull. 1988; 24(3):325-9.
The infection control practitioner as investigator of clinical phenomena. Am J Infect Control. 1987 Oct; 15(5):215-20.
Transmission of human immunodeficiency virus within the health care setting. Occup Med. 1987 Jul-Sep; 2(3):429-50.
Routine surveillance for infections in nursing homes: experience at two facilities. Am J Infect Control. 1987 Apr; 15(2):47-53.
Accuracy of patient recall for date of peripheral intravenous catheter insertion. Am J Infect Control. 1987 Feb; 15(1):26-8.
Prospective microbiologic surveillance in control of nosocomial methicillin-resistant Staphylococcus aureus. Infect Control. 1987 Jan; 8(1):7-14.
On antibiotic prophylaxis in cardiac surgery: a risk factor for wound infection. Ann Thorac Surg. 1986 Dec; 42(6):670-4.
Candidal suppurative peripheral thrombophlebitis: recognition, prevention, and management. Infect Control. 1986 Jan; 7(1):16-22.
Wide variation in risk of wound infection following clean neurosurgery. Implications for perioperative antibiotic prophylaxis. J Neurosurg. 1985 Feb; 62(2):243-7.
Neurosurgical wound infections: methodological and clinical factors affecting calculation of infection rates. J Neurosurg Nurs. 1984 Jun; 16(3):128-33.
Herpes genualius. Infect Control. 1983 Mar-Apr; 4(2):74-5.
David Vlahov
+1 415 476-1805
2 Koret Way, Nursing, Rm 319C
UCSF Box 0604
San Francisco, CA 94143
United States
United States